Premium Nahrungsergänzungsmittel | artgerecht

Pfeiffer Glandular Fever Long-Term Effects

Pfeiffer glandular fever can leave long-term effects. Learn which late complications are possible after EBV infection and when medical follow-up is essential.

Regular tips about health Regular tips about health

Things worth knowing about "Pfeiffer Glandular Fever Long-Term Effects"

Pfeiffer glandular fever can leave long-term effects. Learn which late complications are possible after EBV infection and when medical follow-up is essential.

What Is Pfeiffer Glandular Fever?

Pfeiffer glandular fever, medically known as infectious mononucleosis, is a viral illness caused by the Epstein-Barr virus (EBV). It primarily affects teenagers and young adults, causing fever, swollen lymph nodes, sore throat, and severe fatigue. After the acute phase, EBV remains dormant in the body for life. While most people recover fully, a subset of patients may experience long-term effects or late complications.

Possible Long-Term Effects at a Glance

The long-term consequences of Pfeiffer glandular fever can affect various organ systems and differ in severity. The most common and clinically relevant late effects are described below.

Chronic Fatigue

One of the most frequent long-term effects is persistent, debilitating fatigue that can last weeks to months after the acute illness. In a small proportion of patients, this develops into Chronic Fatigue Syndrome (CFS/ME), significantly reducing quality of life. Key features include extreme exhaustion not relieved by rest, and intolerance to physical or mental exertion.

Splenic Changes and Splenic Rupture

The spleen often enlarges (splenomegaly) during the acute phase. In rare cases, splenic rupture can still occur even after the acute illness, representing a medical emergency. Strenuous activities and contact sports should be avoided until full recovery is confirmed.

Neurological Late Effects

In rare cases, EBV can affect the nervous system. Possible neurological long-term effects include:

Encephalitis (inflammation of the brain)
Meningitis (inflammation of the meninges)
Guillain-Barré syndrome (a peripheral nervous system disorder)
Memory impairment and difficulty concentrating

Cardiac Involvement

A rare but possible late complication is myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the pericardium), which may present with arrhythmias, chest pain, or shortness of breath on exertion.

Liver Damage

Many patients develop hepatitis (liver inflammation) with elevated liver enzymes during the acute phase. This is usually self-limiting, but in rare cases, persistently elevated liver values may remain and should be monitored by a physician.

Association with Other Diseases

Scientific studies indicate possible links between prior EBV infection and certain autoimmune diseases, including:

Multiple sclerosis (MS)
Systemic lupus erythematosus
Rheumatoid arthritis

An association between EBV and certain types of lymphoma (e.g., Burkitt lymphoma, Hodgkin lymphoma) is also discussed, although the absolute risk for affected individuals remains low.

High-Risk Groups for Severe Long-Term Effects

Certain groups face a higher risk of severe or complicated outcomes:

Individuals with immunodeficiency (e.g., HIV infection, post-transplant immunosuppression)
Infants and toddlers with early primary EBV infection
Patients with genetic immune defects (e.g., X-linked lymphoproliferative disease)

When to See a Doctor

After recovering from glandular fever, medical advice should be sought if:

fatigue persists for more than 4–6 weeks
sudden abdominal pain occurs (possible sign of splenic rupture)
neurological symptoms such as numbness or visual disturbances develop
palpitations, chest pain, or shortness of breath are present
jaundice or persistently elevated liver enzymes are detected

Diagnosis and Follow-Up

Follow-up care after glandular fever typically includes blood count and liver enzyme monitoring, ultrasound of the spleen when indicated, and evaluation of neurological or cardiac symptoms. A rise in EBV antibodies in the blood may indicate reactivation of the virus.

Treatment and Support for Long-Term Effects

No specific antiviral therapy against EBV is currently available. Treatment is directed at the specific late complication present:

Fatigue/CFS: Pacing (energy management), cognitive behavioural therapy, symptom-oriented care
Autoimmune diseases: immunomodulatory or immunosuppressive therapy
Hepatitis: liver protection measures, alcohol avoidance, regular monitoring
Neurological complications: specialist neurological care, corticosteroids if indicated

References

Luzuriaga, K. & Sullivan, J. L. (2010). Infectious Mononucleosis. New England Journal of Medicine, 362(21), 1993–2000. DOI: 10.1056/NEJMcp1001116
Dunmire, S. K., Verghese, P. S. & Balfour, H. H. (2018). Primary Epstein-Barr virus infection. Journal of Clinical Virology, 102, 84–92. DOI: 10.1016/j.jcv.2018.03.001
Bjornevik, K. et al. (2022). Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science, 375(6578), 296–301. DOI: 10.1126/science.abj8222

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category